Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan

[1]  M. Manns,et al.  Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases , 2019, Hepatology.

[2]  T. Masaki,et al.  Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis , 2019, Journal of clinical medicine.

[3]  K. Watt,et al.  Autoimmune hepatitis: Current and future therapeutic options , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[4]  T. Masaki,et al.  Albumin–Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study , 2019, The American journal of tropical medicine and hygiene.

[5]  T. Masaki,et al.  Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C , 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  P. Trivedi,et al.  Grand round: Autoimmune hepatitis. , 2019, Journal of hepatology.

[7]  J. Herkel,et al.  Review article: unanswered clinical and research questions in autoimmune hepatitis‐conclusions of the International Autoimmune Hepatitis Group Research Workshop , 2019, Alimentary pharmacology & therapeutics.

[8]  J. McGonigle,et al.  Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UK , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[9]  B. van Hoek,et al.  Role of age in presentation, response to therapy and outcome of autoimmune hepatitis , 2018, Clinical and Translational Gastroenterology.

[10]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[11]  T. Liwinski,et al.  Autoimmune hepatitis - update on clinical management in 2017. , 2017, Clinics and research in hepatology and gastroenterology.

[12]  Yoshiyuki Suzuki,et al.  Autoimmune hepatitis in Japan: trends in a nationwide survey , 2017, Journal of Gastroenterology.

[13]  H. Enomoto,et al.  Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia , 2017, Inflammatory Intestinal Diseases.

[14]  W. Dow,et al.  Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial , 2016, British Medical Journal.

[15]  M. Manns,et al.  Prediction of short‐ and long‐term outcome in patients with autoimmune hepatitis , 2015, Hepatology.

[16]  J. Jia,et al.  Autoimmune hepatitis: East meets west , 2015, Journal of gastroenterology and hepatology.

[17]  M. Manns,et al.  Autoimmune hepatitis--Update 2015. , 2015, Journal of hepatology.

[18]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Kazuhide Yamamoto,et al.  Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013 , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[20]  A. Czaja.  Autoimmune hepatitis in diverse ethnic populations and geographical regions , 2013, Expert review of gastroenterology & hepatology.

[21]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[22]  M. Heneghan,et al.  British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis , 2011, Gut.

[23]  S. Doğan,et al.  Pregabalin-induced hepatotoxicity. , 2011, European journal of gastroenterology & hepatology.

[24]  M. Campbell,et al.  Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center. , 2011, Gastroenterology.

[25]  A. Czaja.  Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria. , 2011, Gastroenterology.

[26]  K. Bennett,et al.  Opt-out as an acceptable method of obtaining consent in medical research: a short report , 2011, BMC medical research methodology.

[27]  E. Ballot,et al.  Significance of antibodies to soluble liver antigen/liver pancreas: a large French study , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[28]  E. Björnsson,et al.  Pregabalin as a probable cause of acute liver injury. , 2008, European journal of gastroenterology & hepatology.

[29]  K. Boberg,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Simplified Criteria for the Diagnosis of Autoimmune Hepatitis , 2008 .

[30]  A. Akobeng.  Understanding diagnostic tests 2: likelihood ratios, pre‐ and post‐test probabilities and their use in clinical practice , 2007, Acta paediatrica.

[31]  G Molenberghs,et al.  Model selection for incomplete and design‐based samples , 2006, Statistics in medicine.

[32]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[33]  Viv Bewick,et al.  Statistics review 8: Qualitative data – tests of association , 2003, Critical care.

[34]  J. Herkel,et al.  Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics , 2002, Gut.

[35]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[36]  O. Chazouilleres,et al.  Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy , 1998, Hepatology.

[37]  K. Meyer zum Büschenfelde,et al.  Autoimmune hepatitis--an update. , 1992, Behring Institute Mitteilungen.

[38]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[39]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[40]  M. Rowley,et al.  Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. , 1992, Progress in liver diseases.